# ClinicalTrials.gov record NCT01916265

> PeptideScanner retained ClinicalTrials.gov record NCT01916265 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-05, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct01916265-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-02-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01916265-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01916265-glucagon-v1.json
- Content SHA-256: `a7e8fd186ce219bc2c8312abb8cc91a6b89bd72c0ee87b46251d8f75f18ddf3c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01916265 ([`ctg-observation-nct01916265-2014-02-05-ca71b1e0a481`](#source-ctg-observation-nct01916265-2014-02-05-ca71b1e0a481))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01916265 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-05, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct01916265-2014-02-05-ca71b1e0a481`](#source-ctg-observation-nct01916265-2014-02-05-ca71b1e0a481))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01916265 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-05, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct01916265-2014-02-05-ca71b1e0a481`](#source-ctg-observation-nct01916265-2014-02-05-ca71b1e0a481))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01916265-2014-02-05-ca71b1e0a481`](#source-ctg-observation-nct01916265-2014-02-05-ca71b1e0a481))

## Sources

<a id="source-ctg-observation-nct01916265-2014-02-05-ca71b1e0a481"></a>
- **ClinicalTrials.gov record NCT01916265 · retained source version 2014-02-05:ca71b1e0a4811fdfe6d1e17a8ae4ea8e55ed4dd86613c446b185326dee2e5170** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01916265) (`ctg-observation-nct01916265-2014-02-05-ca71b1e0a481`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01916265." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01916265-glucagon-v1.json SHA-256: a7e8fd186ce219bc2c8312abb8cc91a6b89bd72c0ee87b46251d8f75f18ddf3c.